» Articles » PMID: 20159979

AMSH Interacts with ESCRT-0 to Regulate the Stability and Trafficking of CXCR4

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Feb 18
PMID 20159979
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Reversible ubiquitination is essential for the endocytic sorting and down-regulation of G protein-coupled receptors, such as the chemokine receptor CXCR4. The deubiquitinating enzyme AMSH has been implicated in the endocytic sorting of both G protein-coupled receptors and receptor-tyrosine kinases. Herein, we examine the role of AMSH in the regulation of CXCR4 stability and trafficking and characterize protein-protein interactions critical for this function. Loss of AMSH catalytic activity or depletion by RNAi results in increased steady-state levels of CXCR4 under basal conditions. Analysis of truncation and point mutation of AMSH reveal the importance of an RXXK motif for CXCR4 degradation. The RXXK motif of AMSH interacts with the SH3 domains of the STAM and Grb2 families of adaptor proteins with high affinity. Cells expressing a catalytically inactive mutant of AMSH show basal hyperubiquitination, but not increased degradation, of the ESCRT-0 components STAM1 and Hrs. This is dependent on the RXXK motif of AMSH. Ubiquitination of endocytic machinery modulates their activity, suggesting that AMSH may directly regulate endocytic adaptor protein function. This is reflected in CXCR4 trafficking and provides a mechanism by which AMSH specifies the fate of endocytosed receptors. Taken together, these studies implicate AMSH as a key modulator of receptor fate determination through its action on components of the endocytic machinery.

Citing Articles

Analysis of the neuromuscular deficits caused by STAM1 deficiency.

McLean J, VanHart M, McWilliams M, Farmer C, Crossman D, Cowell R Curr Res Neurobiol. 2024; 7:100138.

PMID: 39280771 PMC: 11401115. DOI: 10.1016/j.crneur.2024.100138.


Ubiquitin and its relatives as wizards of the endolysosomal system.

Berlin I, Sapmaz A, Stevenin V, Neefjes J J Cell Sci. 2023; 136(4).

PMID: 36825571 PMC: 10022685. DOI: 10.1242/jcs.260101.


Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease.

Pan X, Wu S, Wei W, Chen Z, Wu Y, Gong K Biomolecules. 2022; 12(7).

PMID: 35883466 PMC: 9313428. DOI: 10.3390/biom12070910.


Ubiquitination of the ubiquitin-binding machinery: how early ESCRT components are controlled.

Korbei B Essays Biochem. 2022; 66(2):169-177.

PMID: 35352804 PMC: 9400068. DOI: 10.1042/EBC20210042.


The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome.

Bednash J, Johns F, Patel N, Smail T, Londino J, Mallampalli R Cell Signal. 2020; 79:109859.

PMID: 33253913 PMC: 10201604. DOI: 10.1016/j.cellsig.2020.109859.


References
1.
Komada M, Kitamura N . The Hrs/STAM complex in the downregulation of receptor tyrosine kinases. J Biochem. 2005; 137(1):1-8. DOI: 10.1093/jb/mvi001. View

2.
Nakamura M, Tanaka N, Kitamura N, Komada M . Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes. Genes Cells. 2006; 11(6):593-606. DOI: 10.1111/j.1365-2443.2006.00963.x. View

3.
Wojcik C . Two blades of a sword: degradation coupled to deubiquitination. Trends Cell Biol. 2002; 12(12):549. DOI: 10.1016/s0962-8924(02)02398-x. View

4.
Moffat J, Grueneberg D, Yang X, Kim S, Kloepfer A, Hinkle G . A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006; 124(6):1283-98. DOI: 10.1016/j.cell.2006.01.040. View

5.
Liu Q, Berry D, Nash P, Pawson T, McGlade C, Li S . Structural basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel mode of peptide recognition. Mol Cell. 2003; 11(2):471-81. DOI: 10.1016/s1097-2765(03)00046-7. View